John Duncan Higgons

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Caroline Gammill, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Duncan Higgons:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 24 Jun 2022 Direct

Insider Reports Filed by John Duncan Higgons

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000164045522000070-higgons-john-duncan-2022-06-24 Jounce Therapeutics, Inc. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 21:03
/report/000164045521000111-higgons-john-duncan-2021-06-18 Jounce Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:46